Published in Eur Neuropsychopharmacol on July 01, 2000
High activity of acid sphingomyelinase in major depression. J Neural Transm (Vienna) (2005) 1.21
The molecular neurobiology of depression. Psychiatr Clin North Am (2007) 1.02
The role of ceramide in major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2009) 0.96
Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci (2002) 0.84
Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. Psychiatry Res (2012) 0.84
Electroacupuncture pretreatment exhibits anti-depressive effects by regulating hippocampal proteomics in rats with chronic restraint stress. Neural Regen Res (2015) 0.78
NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER. Transl Neurosci (2013) 0.78
Risperidone for psychotic and behavioural symptoms in Lewy body dementia. Lancet (1995) 1.43
Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy. Epilepsia (1978) 1.43
Capgras syndrome in association with lithium toxicity. Br J Psychiatry (1991) 1.41
Physiology of status epilepticus in primates. Arch Neurol (1973) 1.40
Rapid detection of highly pathogenic avian influenza H5N1 virus by TaqMan reverse transcriptase-polymerase chain reaction. Avian Dis (2007) 1.31
Gender differences in muscle inflammation after eccentric exercise. J Appl Physiol (1985) (2000) 1.26
Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase. Br J Pharmacol (1973) 1.24
A primate model for testing anticonvulsant drugs. Arch Neurol (1975) 1.18
Detecting and managing depression in older people. Br J Gen Pract (1996) 1.17
Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl) (1990) 1.12
Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose. J Neurochem (1973) 1.10
Diagnosing Alzheimer's disease. BMJ (1992) 1.08
Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br J Psychiatry (1997) 1.05
The behavioural effects of manipulating GABA function in the globus pallidus. Brain Res (1976) 1.04
Endurance exercise training attenuates leucine oxidation and BCOAD activation during exercise in humans. Am J Physiol Endocrinol Metab (2000) 1.03
Pharmacological strategies in depression. Br J Hosp Med (1985) 0.97
Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures. Biochem Pharmacol (1976) 0.94
Serotonin concentrations and turnover in brains of depressed suicides. Brain Res (1989) 0.94
Brain alpha-adrenoceptors in depressed suicides. Brain Res (1997) 0.92
Photically induced epilepsy in Papio papio as a model for drug studies. Adv Neurol (1975) 0.92
Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res (1988) 0.92
5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J Affect Disord (1997) 0.92
Epileptic brain damage in adolescent baboons following seizures induced by allylgycine. Brain (1974) 0.91
NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides. Brain Res (1993) 0.91
Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. Eur J Nucl Med (1997) 0.89
In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet (1999) 0.87
Endocrine factors and glucose metabolism during prolonged seizures in baboons. Epilepsia (1979) 0.87
Suicide rates in Hungary correlate negatively with reported rates of depression. J Affect Disord (1990) 0.87
Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res (1988) 0.87
Regional cerebral blood flow in the rat during prolonged seizure activity. Brain Res (1980) 0.86
Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA. Eur J Pharmacol (1979) 0.86
Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Br J Pharmacol (1997) 0.86
Alpha 2-adrenoceptors in depression. Psychiatr Dev (1987) 0.85
Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry (2000) 0.85
Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine. Psychopharmacology (Berl) (1993) 0.85
Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res (1997) 0.85
Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate. Eur J Pharmacol (1977) 0.85
Electroencephalographic and behavioral effects of a GABA agonist (muscimol) on photosensitive epilepsy in the baboon, papio papio. Epilepsia (1979) 0.84
Possible GABA-mediated control of dopamine-dependent behavioural effects from the nucleus accumbens of the rat. Psychopharmacology (Berl) (1976) 0.84
Benzodiazepine and GABAA receptors in rat brain following chronic antidepressant drug administration. Biochem Pharmacol (1987) 0.83
Are increases in GABAB receptors consistent findings following chronic antidepressant administration? Eur J Pharmacol (1987) 0.83
Low and high energy ECT. Br J Psychiatry (1983) 0.83
Physiological observations during prolonged epileptic seizures in primates and their relation to subsequent brain damage. J Physiol (1972) 0.83
Corticotropin-releasing factor binding sites in cortex of depressed suicides. Psychopharmacology (Berl) (1997) 0.83
Cerebral functional effects of 2-deoxy-D-glucose and 3-O-methylglucose in rhesus monkeys. Electroencephalogr Clin Neurophysiol (1973) 0.83
Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5-HT2 binding site changes. Br J Pharmacol (1988) 0.82
Clobazam: anticonvulsant action in animal models of epilepsy [proceedings]. Br J Clin Pharmacol (1979) 0.82
Regional changes in cerebral GABA concentration and convulsions produced by D and by L-allylglycine. J Neurochem (1978) 0.82
Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res (1994) 0.82
gamma-Aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice. J Neurochem (1982) 0.81
Convulsive effects of 4-deoxypyridoxine and of bicuculline in photosensitive baboons (Papio papio) and in rhesus monkeys (Macaca mulatta). Brain Res (1971) 0.81
Psychiatric admissions and social deprivation: is the Jarman underprivileged area score relevant? J Epidemiol Community Health (1992) 0.81
Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177. Eur J Pharmacol (1989) 0.81
Cytochalasin B inhibition of brain glucose transport and the influence of blood components on inhibitor concentration. Biochim Biophys Acta (1977) 0.81
Long-lasting convulsant effect on the cerebral cortex of Naja naja venom. Br J Pharmacol (1970) 0.81
Interactions of 5-hydroxytryptamine and gamma-aminobutyric acid with dopamine. Adv Biochem Psychopharmacol (1978) 0.80
Diagnosing and treating dementia. BMJ (1989) 0.80
Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine. J Neural Transm (1987) 0.80
Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res (1997) 0.80
Picrotoxin convulsions and GABA metabolism after injection of anticonvulsants in chicks. Eur J Pharmacol (1976) 0.79
GTP gamma S and forskolin-stimulated adenylyl cyclase activity in post-mortem brain from depressed suicides and controls. Mol Psychiatry (1996) 0.79
Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists. J Affect Disord (1997) 0.79
Regional heterogeneity of benzodiazepine binding sites in rat brain. Eur J Pharmacol (1982) 0.79
3H-imipramine binding to previously frozen platelet membranes from depressed patients, before and after treatment. Br J Psychiatry (1990) 0.79
Catalytic inhibitors of GABA-transaminase as anticonvulsants in baboons with photosensitive epilepsy [proceedings]. Br J Pharmacol (1978) 0.79
Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry (1999) 0.79
Brain GABAB binding sites in depressed suicide victims. Psychiatry Res (1988) 0.79
The distribution of 5-HT1D and 5-HT1E binding sites in human brain. Eur J Pharmacol (1992) 0.79
Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. Psychopharmacology (Berl) (1994) 0.79
Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA. Epilepsia (1975) 0.79
Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Res (1990) 0.79
Somatostatin immunoreactivity in postmortem brain from depressed suicides. Arch Gen Psychiatry (1988) 0.78
Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res (1990) 0.78
Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls. J Psychiatry Neurosci (1997) 0.78
Susceptibility to drug-induced hypotension in post-partum psychosis. Int Clin Psychopharmacol (1986) 0.78
Virus strains from a flock exhibiting unusually high mortality due to infectious bursal disease. Aust Vet J (2004) 0.78